Notice of Intent to Publish a Funding Opportunity Announcement for Early-Stage Pharmacological Validation of Novel Targets and Accompanying Pre-Therapeutic Leads for Diseases of Interest to the NIDDK (R01)

Most Recent Update:	05/24/2013 10:28:19 AM
denotes Help Information **   denotes change from the most previous version
Summary:
Funding Opportunity Number:	NOT-DK-12-010
Forecast ID Number:	NIH-2013-FCAST-0008
Fiscal Year:	2013
Funding Opportunity Title:	Notice of Intent to Publish a Funding Opportunity Announcement for Early-Stage Pharmacological Validation of Novel Targets and Accompanying Pre-Therapeutic Leads for Diseases of Interest to the NIDDK (R01)
CFDA Number:	93.847
** Funding Activity Category:	Health (HL)
CFDA Number Description:	Prevention and Control Specialized Health Research and Training
Funding Instrument Type Code(s):	Grant
Cost Sharing / Matching Requirement:	No
Recovery Act:
Affordable Care Act (ACA):	No
Estimated Funding Information:
Estimated Funding:
Expected Number of Awards:
Estimated Award Ceiling:
Estimated Award Floor:
Estimated Milestone Dates:
Estimated Post Date:	09/28/2012
Estimated Application Due Date:	02/05/2013
Estimated Award Date:	12/01/2013
Estimated Start Date:
Eligibility:
Eligibility Category:	State governments County governments City or township governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
** Additional Eligibility Information:
** Description:
?The National Institute of Diabetes and Digestive and Kidney Disease intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to promote translation of basic science research into knowledge and tools that can be utilized to provide strong justification for later-phase drug discovery and development efforts in areas relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, hematology, and specific aspects of cystic fibrosis. For additional information on disease areas of interest to the NIDDK, please seehttp://www2.niddk.nih.gov/Research/.ÿIts objective is to stimulate research and technology development to promote the early-stage pharmacological validation of drug targets and accompanying small molecule chemical scaffolds or non-viral biologics that are not currently a focus within the biotechnology and pharmaceutical industries. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.ÿ The FOA is expected to be published in October, 2012 with an expected receipt date in February, 2013. This FOA will utilize the R01 activity code. Details of the planned FOA are provided below.?
Federal Agency Contact Information:
Federal Agency:	Department of Health and Human Services
Name:	Dr. Aaron Pawlyk
Email Address:	pawlykac@niddk.nih.gov
Phone:	3014517299
OpDiv:	National Institutes of Health
Sub OpDiv:	DK
Modification History:
Date Modified Version 05/24/2013 10:28:19 AM 7 04/16/2013 12:47:12 PM 6 01/08/2013 03:07:06 PM 5 12/07/2012 01:52:26 PM 4 11/15/2012 01:31:07 PM 3 11/08/2012 04:39:17 PM 2 09/10/2012 06:48:25 AM 1
<< Back to Search Results